Sorrento and NantWorks team up again
Sorrento Therapeutics Inc. and NantWorks Inc. have entered into their second agreement in less than six months, again centered around the development of immunotherapies for cancer.
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com